A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets

Clinical trial NCT02063854 · COMPLETED

Trial details

NCT number: NCT02063854
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Involutional Osteoporosis

Start date: 2014-02-01
Primary completion: 2015-11-01
Enrollment: 871

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.